(3) Among the studied microRNAs related to the DNA damage response pathway, miRNA-23a could serve as a screening biomarker with a suitable diagnostic behavior, which overtakes AFP, for early detection of HCC patients (who are previously infected with HCV). Here, AFP is linked to hepatocellular carcinoma.